TRANSCRIPT TO FOLLOW
The information contained within is for educational and informational purposes ONLY. It is not intended nor should it be considered an invitation or inducement to buy or sell a security or securities noted within nor should it be viewed as a communication intended to persuade or incite you to buy or sell security or securities noted within. Any commentary provided is the opinion of the author and should not be considered a personalised recommendation. The information contained within should not be a person's sole basis for making an investment decision. Please contact your financial professional before making an investment decision.
Warren Buffett once again extolled the virtues of passive funds in his recent Berkshire H...
Retired investor Malcolm Wright doesn’t need an income from his equity portfolio. He is ...
Value investing has been successfully implemented since the 1930s - sti...
So much of Berkshire Hathaway's investment success is down to the culture created by its two l...
Buffett may have paid a premium for some of his recent purchases, but these defensive, high-qu...
Mining companies are operating in a challenging environment but could now be the time to top up o...
THE WEEK: Morningstar columnist Rodney Hobson provides two pieces of advice to George Osborne, an...
Businesses that have competitive advantages within their industry are good candidates for dividen...
Morningstar reveals the top 10 best performers over the last five years
Morningstar OBSR reveals the top funds for investors seeking exposure to European equities
The bank also announced a deal with Metro Bank, raised its guidance, and increased its dividends
With revenue growth, increased operating margins, but a high valuation, here’s what we think of N...
We'll be watching iPhone revenue, gross margins, and services growth when Apple reports its earni...
Despite growth, Morningstar's Fair Value Estimate for the consumer goods giant stock is unchanged
Morningstar analysts think the UK's biggest company has a well-positioned broad drug portfolio wh...
Security Name | Price | Change (%) | Morningstar Rating |
---|---|---|---|
Berkshire Hathaway Inc Class A | 657,179.99 USD | 1.11 | ![]() |
Berkshire Hathaway Inc Class B | 437.66 USD | 1.01 | ![]() |
Jeremy Glaser is markets editor for Morningstar.com, the sister site of Morningstar.co.uk.